Document is current
Any future updates will be listed below
-
Authors
Chen, Lu https://orcid.org/0000-0001-9347-291X
Krekels, Elke H. J. https://orcid.org/0000-0001-6006-1567
Verweij, Paul. E. https://orcid.org/0000-0002-8600-9860
Buil, Jochem B. https://orcid.org/0000-0003-4031-0778
Knibbe, Catherijne A. J. https://orcid.org/0000-0001-9893-4415
Brüggemann, Roger J. M. https://orcid.org/0000-0002-7618-725X
- License Information
-
More Information
Article History
First Online: 22 April 2020
Compliance with ethical standards
:
: No disclosures are applicable for this work. Disclosures outside of this work: R.J.B. and P.V have served as consultants to Astellas Pharma, Inc., F2G, Amplyx, Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc., and have received unrestricted and research grants from Astellas Pharma, Inc., Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc. All contracts were through Radboudumc, and all payments were invoiced by Radboudumc. None of the other authors have a conflict to declare.
